SNDX compared with URGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SNDXSyndax Pharmaceuticals Inc

Mkt capRevenueRevenue

URGNUroGen Pharma Ltd.

Mkt capRevenueRevenue

Compare

SNDXSyndax Pharmaceuticals Inc

URGNUroGen Pharma Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SNDX: latest quarter is a loss; flow not drawable. URGN: latest quarter is a loss; flow not drawable.Method ›

SNDXSyndax Pharmaceuticals Inc

13.13▼−3.80%

Mkt cap$1.2BRevenue$73MQ2 FY26Revenue$172MFY25

URGNUroGen Pharma Ltd.

32.82▲+0.31%

Regular sessionSep 2 '83

Mkt cap$1.6BRevenue$72MQ2 FY26Revenue$110MFY25

Compare

Regular sessionSep 2 '83

SNDXSyndax Pharmaceuticals Inc

URGNUroGen Pharma Ltd.

13.13▼−3.80%

Price

32.82▲+0.31%

$1.2B

Mkt cap

$1.6B

Q2 FY26$73M

Revenue

$72MQ2 FY26

FY25$172M

Revenue

$110MFY25

SNDX13.13▼−3.80%vsURGN32.82▲+0.31%Regular sessionSep 2 '83

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SNDX 3

ABBVAbbViesupplier

RPRXRoyalty Pharmacustomer

—Eddingpharmunlistedcustomer

Shared 0

No shared counterparties.

Only URGN 6

AGENAgenussupplier

TEVATeva Pharmaceuticals Industriessupplier

—Cenexi-Laboratories Thissenunlistedsupplier

—IconOVir Bio

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

2 more · URGN chain ›

Price

rebased to 0%

SNDX, solidURGN, dashed